Topline Phase III Efpeglenatide Data Raise Hopes For Hanmi’s Obesity Contender

Korea Approval Filing Eyed This Year

 
• By Jung Won Shin
  
Obesity
Hanmi Expects Efpeglenatide To Show Expandability In Metabolic Diseases (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D